$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
The safest and simplest method to handle when discontinuing Pitobrutinib/Pitobrutinib (Zepali)
2026-02-01 22:25:32
Check Details
Detailed description of the side effects and potential harms of Talazoparib (Tazena)
2026-02-01 22:25:32
Check Details
Crizotinib manufacturer and brand credibility analysis
2026-02-01 22:25:32
Check Details
Omarigliptin price list and drug purchase channels and cost reference
2026-02-01 22:25:32
Check Details
Lecanemab-LEQEMBI treatment cost, medical insurance and self-payment information
2026-02-01 22:25:32
Check Details
Description of golodirsen’s domestic and overseas launch time and clinical availability channels
2026-02-01 22:25:32
Check Details
Analysis of the treatment schedule, usage and dosage and clinical use guidelines of Vidicitomab (Aidexi)
2026-02-01 22:25:32
Check Details
Isatuximab (Isatuximab) price, market reference and analysis of drug purchase channels in various regions
2026-02-01 22:25:32
Check Details
Analysis of the targeted mechanism of action, indications and clinical efficacy of caposetinib tablets
2026-02-01 22:25:32
Check Details
Analysis of domestic and overseas marketing status, clinical progress and R&D dynamics of Guselkumab
2026-02-01 22:25:32
Check Details
Application and efficacy evaluation of tenapano (Ventile) combination therapy
2026-02-01 22:25:32
Check Details
How much does Lapatinib cost per month?
2026-02-01 22:25:32
Check Details
1
2
...
2372
2373
2374
2375
2376
2377
2378
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma